Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM42852
Volume:
9 |
5 |
May 2025
Pages:
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
A popular topical medication with keratolytic, antibacterial, and anti-inflammatory qualities is benzoyl peroxide (BPO). Because of its capacity to lower populations of Cutibacterium acnes (previously Propionibacterium acnes) and reduce inflammation within the pilosebaceous unit, it is mostly used to treat acne vulgaris. As a strong oxidizing agent, BPO breaks down bacterial cell walls by producing reactive oxygen species. Furthermore, it promotes pore unclogging and prevents comedone formation by facilitating the shedding of dead skin cells. BPO is often combined with other acne therapies, such as topical retinoids or antibiotics, to enhance efficacy and reduce bacterial resistance. Common side effects include dryness, redness, and irritation, which can be mitigated by adjusting concentrations or frequency of application. Advances in formulation, such as microencapsulation and water-based gels, have improved tolerability. Beyond acne, BPO shows promise in treating other skin conditions, including folliculitis and as a decolonization agent for Staphylococcus aureus. Despite its benefits, appropriate use and patient education are crucial to minimize side effects and optimize outcomes.
KEYWORDS
Publication Date
5/31/2025
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
2
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...